Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific: a Multicenter, Prospective Registry (ENDURE-APAC)

NCT05578300 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT05578300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05578300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific: a Multicenter, Prospective Registry (ENDURE-APAC)
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Recruiting
Start date
October 21, 2022
Completion date
December 31, 2032
Enrollment
350 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain diseases, ischemic stroke, major adverse cardiovascular event, stroke, stroke, acute, stroke, ischemic